Table 2.
The mean ± SD (range) scores for global and component PSQI, SF-36 MCS and PCS, MMSE, and HAD depression and anxiety domains for all patients
| Variable | All patients | Diabetic | Non-diabetic |
|---|---|---|---|
| Quality of life | |||
| MCS | 40.8± 10.4 | 37.7±9.6 | 41.8±10.5 |
| PCS | 39.0±8.2 | 38.5±6.3 | 39.2±8.8 |
| Physical functioning | 50.8± 28.2 | 47.2±26.7 | 52.0±28.7 |
| Role-physical | 42.0± 36.8 | 35.6±37.5 | 44.0±36.6 |
| Bodily pain | 58.3± 23.0 | 58.2±21.2 | 58.3±23.7 |
| General health | 45.0± 12.9 | 41.0±11.6 | 46.4±13.1 |
| Vitality | 52.2± 22.5 | 47.6±21.0 | 53.7±22.9 |
| Social functioning | 58.3± 25.4 | 55.6±24.7 | 59.2±25.7 |
| Role-emotional | 37.3± 36.4 | 25.3±31.7 | 41.3±37.1 |
| Mental health | 54.9± 21.3 | 51.2±21.5 | 56.2±21.2 |
| Quality of sleep | |||
| Global PSQI | 7.8± 2.8 | 7.4±2.8 | 7.9±2.8 |
| Sleep quality | 1.1± 0.7 | 1.1±0.6 | 1.2±0.8 |
| Sleep latency | 1.4± 0.8 | 1.4±0.7 | 1.3±0.8 |
| Sleep duration | 0.8± 0.7 | 0.5±0.6 | 0.9±0.7 |
| Sleep efficiency | 1.4± 1.4 | 0.8±1.2 | 1.5±1.4 |
| Sleep disturbance | 1.7± 0.6 | 1.7±0.5 | 1.7±0.6 |
| Use of sleep medications | 0.7± 0.8 | 0.7±0.9 | 0.7±0.8 |
| Day time dysfunction | 1.1± 0.7 | 7.4±2.8 | 7.9±2.8 |
| MMSE | 22.0± 4.5 | 21.9±3.5 | 22.0±4.8 |
| HAD | |||
| Depression | 8.1± 4.3 | 8.2±3.8 | 8.1±4.5 |
| Anxiety | 7.3± 3.8 | 7.0±3.8 | 7.5±3.8 |
PSQI: Pittsburgh Sleep Quality Index; MCS: SF-36 Mental Component Summary; PCS: SF- 36 Physical Component Summary; MMSE: Mini-Mental State Examination; HSD: Hospital Anxiety and Depression Scale.